Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$11.5M Buy
59,620
+3,190
+6% +$612K 0.36% 60
2019
Q2
$10.4M Buy
56,430
+20,218
+56% +$3.62M 0.33% 68
2019
Q1
$6.88M Buy
36,212
+8,734
+32% +$1.67M 0.23% 89
2018
Q4
$5.35M Buy
27,478
+6,358
+30% +$1.24M 0.21% 95
2018
Q3
$4.38M Sell
21,120
-3,828
-15% -$754K 0.14% 140
2018
Q2
$4.61M Sell
24,948
-15,070
-38% -$2.67M 0.15% 131
2018
Q1
$6.82M Sell
40,018
-5,786
-13% -$1.06M 0.24% 86
2017
Q4
$7.96M Buy
45,804
+6,094
+15% +$1.08M 0.29% 75
2017
Q3
$7.4M Sell
39,710
-2,200
-5% -$390K 0.28% 81
2017
Q2
$7.22M Buy
41,910
+7,260
+21% +$1.18M 0.27% 74
2017
Q1
$5.68M Buy
34,650
+6,336
+22% +$1.05M 0.23% 90
2016
Q4
$4.14M Buy
+28,314
New +$4.26M 0.19% 103

Other funds holding AMGN

Neuburgh Advisers's AMGN Position: Q3 2019 in Review

Neuburgh Advisers increased its Amgen (AMGN) stake by 5.7% in Q3 2019, buying an estimated $612K and bringing the position to 59,620 shares worth $11.5M. The position accounts for 0.36% of the portfolio, ranked #60.

Neuburgh Advisers first reported a position in AMGN in Q4 2016 and has held it in 12 quarters since. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Neuburgh Advisers held 59,620 shares of Amgen worth $11.5M as of Q3 2019.
  • Neuburgh Advisers bought 3,190 Amgen shares in Q3 2019, an estimated $612K.
  • Amgen made up 0.36% of Neuburgh Advisers's portfolio in Q3 2019, its #60 holding.
  • Neuburgh Advisers first reported a position in Amgen in Q4 2016 and has held it in 12 quarters since.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.